Does plasma fibrinogens and C-reactive protien predicts the incidence of myocardial infraction in patients with normal lipids profile?

Pakistan Journal of Medical Sciences

Volumn 24, Issue 2, 2008, Pages 336-339

  Kumar, Arun ^a   Sivakanesan, Ramiah ^b  

^a MUZAFFARNAGAR MEDICAL COLLEGE   (India)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

C reactive proteins and AMI; Normal lipid profile; Plasma fibrinogen

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INCIDENCE; INDIAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STUDENT T TEST; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 44849089426     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mendis S, Wissler R. A Nutritional experiment to study short term effects of coconut in diet on serum cholesterol and platelet factor 4 in man. Scientific Proceedings of the International Congress on Coronary Heart Disease Conference; 1988;18-21; Bombay, India.
2. Neaton JD, Wentworth D. Multiple Risk Factor Intervention Trial Research Group.Serum cholesterol, blood pressure, cigarette smoking, and Death from coronary heart disease. Overall findings and differences by age for 316099 white men. Arch Intern Med 1992;152:56-64.
3. Gould AL, Roussouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit. Impact of statin trials. Circulation 1998;97:946-52.
4. Ridker PM. Evaluating novel cardiovascular risk cfactors: Can we better predict heart attack? Ann Intern Med 1999;130:933-7.
5. Gil M, Zarebinski M, Adamus J. Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina. Int J Cardiol 2002;83:43-6.
6. Ridker PM, Stamper MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and standard cholesterol screening predictors of peripheral arterial disease. JAMA 2001;285:2481-5.
7. Smith EB, Crospbie L. Fibrinogen and fibrin in atherogenesis. In: Ernst E, Koeing W, Lowe GD, Meade TW, eds, Fibrinogen: a new cardiovascular risk factor. Wein: Blackwell, 1992;4-10.
8. Seifried E, Oethinger M, Tansewell P, Hoegee-de Nobel E, Nieuwenhuizen W. Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen. Thromb Haemost 1993;69:321-7.
9. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, Larson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
10. Tataru MC, Schulte H, von Eckardstein A, Heinrich J, Assmann G, Koehler E. Plasma fibrinogen inrelation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Coron Artery Dis 2001;12:157-65.
11. Kindmark CO. The concentration of C-reactive protein in Sera from Healthy Individuals. Scand J Clin Lab Invest 1972;29:407-11.
12. Stefan Wagener. National Committee for Clinical Laboratory Standards: Guidelines for the Standardized Collection, Transport and Preparation of Blood Specimens for Coagulation Testing and Performance of Coagulation Assays. American Biological Safety Association (April 5, 2004), http://www.absa.org/ 0404nccls.html
13. Reddy KS. Neglecting cardiovascular disease is unaffordable. Bulletin of WHO 2001;79:984-5.
14. Reddy KS. Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health. Public Health Nutr 2002;51:231-7.
15. Gheye S, Lakshmi AV, Krishna TP, Krishnaswamy K. Fibrinogen and Homocysteine levels in coronary artery disease. Ind Heart J 1999;51:499-502.
16. Deepa R, Velmurugan K, Saravanan G, Dwarkanath V, Agarwal S, Mohan V. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects. J Assoc Physicians Ind 2002;50:901-6.
17. Chambers JC, Obeid OA, Refsum H, Ueland P, Hackett D, Hooper J, et al. EORTC Breast cancer group and EORTC radiotherapy group. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000;355:523-7.
18. Ridker PM. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-18.
19. Berton G, Cordiano R, Palmieri R, Pianca S, Pagliara V, Palatini P. C-Reactive Protein in Acute Myocardial Infarction: Association with Heart Failure. Am Heart J 2003;145:1094-1101.
20. Rosenson RS, Koenig W. Utility of inflammatory markers in the management of coronary artery disease. Am J Cardiol 2003;92(Suppl):10i-18i.